165 related articles for article (PubMed ID: 33985952)
1. MRI-Visible Perivascular Spaces in the Centrum Semiovale Are Associated with Brain Amyloid Deposition in Patients with Alzheimer Disease-Related Cognitive Impairment.
Kim HJ; Cho H; Park M; Kim JW; Ahn SJ; Lyoo CH; Suh SH; Ryu YH
AJNR Am J Neuroradiol; 2021 Jul; 42(7):1231-1238. PubMed ID: 33985952
[TBL] [Abstract][Full Text] [Related]
2. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
Kamagata K; Andica C; Takabayashi K; Saito Y; Taoka T; Nozaki H; Kikuta J; Fujita S; Hagiwara A; Kamiya K; Wada A; Akashi T; Sano K; Nishizawa M; Hori M; Naganawa S; Aoki S;
Neurology; 2022 Dec; 99(24):e2648-e2660. PubMed ID: 36123122
[TBL] [Abstract][Full Text] [Related]
3. Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum.
Jeong SH; Cha J; Park M; Jung JH; Ye BS; Sohn YH; Chung SJ; Lee PH
Neurology; 2022 Oct; 99(16):e1791-e1802. PubMed ID: 35985826
[TBL] [Abstract][Full Text] [Related]
4. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
[TBL] [Abstract][Full Text] [Related]
5. Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease.
Kim S; Na HK; Sun Y; Yoon YJ; Chung SJ; Sohn YH; Lyoo CH; Lee PH
Neurology; 2024 Jun; 102(12):e209483. PubMed ID: 38833653
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment: A Single Clinic-based Study in South Korea.
Jung NY; Je Y; Ham HG; Park YH; Kim TY; Go MS; Lee HI; Kim DE; Lee MJ; Seo SW; Kim EJ
Alzheimer Dis Assoc Disord; 2024 Apr-Jun 01; 38(2):201-204. PubMed ID: 38563235
[TBL] [Abstract][Full Text] [Related]
7. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
[TBL] [Abstract][Full Text] [Related]
8. Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces.
Pinheiro A; Demissie S; Scruton A; Charidimou A; Parva P; DeCarli C; Seshadri S; Romero JR
Ann Neurol; 2022 Jul; 92(1):23-31. PubMed ID: 35373386
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Low-Dose
Chen KT; Gong E; de Carvalho Macruz FB; Xu J; Boumis A; Khalighi M; Poston KL; Sha SJ; Greicius MD; Mormino E; Pauly JM; Srinivas S; Zaharchuk G
Radiology; 2019 Mar; 290(3):649-656. PubMed ID: 30526350
[TBL] [Abstract][Full Text] [Related]
10. MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample.
Pase MP; Pinheiro A; Rowsthorn E; Demissie S; Hurmez S; Aparicio HJ; Rodriguez-Lara F; Gonzales MM; Beiser A; DeCarli C; Seshadri S; Romero JR
J Alzheimers Dis; 2023; 96(1):103-112. PubMed ID: 37742645
[TBL] [Abstract][Full Text] [Related]
11. Autoidentification of perivascular spaces in white matter using clinical field strength T
Schwartz DL; Boespflug EL; Lahna DL; Pollock J; Roese NE; Silbert LC
Neuroimage; 2019 Nov; 202():116126. PubMed ID: 31461676
[TBL] [Abstract][Full Text] [Related]
12. MRI-Visible Perivascular Spaces and Risk of Incident Dementia: The Framingham Heart Study.
Romero JR; Pinheiro A; Aparicio HJ; DeCarli CS; Demissie S; Seshadri S
Neurology; 2022 Dec; 99(23):e2561-e2571. PubMed ID: 36175148
[TBL] [Abstract][Full Text] [Related]
13. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack.
Arba F; Quinn TJ; Hankey GJ; Lees KR; Wardlaw JM; Ali M; Inzitari D;
Int J Stroke; 2018 Jan; 13(1):47-56. PubMed ID: 27543501
[TBL] [Abstract][Full Text] [Related]
14. Increased perivascular space volume in white matter and basal ganglia is associated with cognition in Parkinson's Disease.
Donahue EK; Foreman RP; Duran JJ; Jakowec MW; O'Neill J; Petkus AJ; Holschneider DP; Choupan J; Van Horn JD; Venkadesh S; Bayram E; Litvan I; Schiehser DM; Petzinger GM
Brain Imaging Behav; 2024 Feb; 18(1):57-65. PubMed ID: 37855955
[TBL] [Abstract][Full Text] [Related]
15. Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T.
Piantino J; Boespflug EL; Schwartz DL; Luther M; Morales AM; Lin A; Fossen RV; Silbert L; Nagel BJ
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2139-2145. PubMed ID: 33033050
[TBL] [Abstract][Full Text] [Related]
16. Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease.
McKnight CD; Trujillo P; Lopez AM; Petersen K; Considine C; Lin YC; Yan Y; Kang H; Donahue MJ; Claassen DO
Parkinsonism Relat Disord; 2021 Aug; 89():98-104. PubMed ID: 34271425
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid is associated with midbrain enlarged perivascular spaces: Results from Multi-modality Medical imaging sTudy bAsed on KaiLuan Study (META-KLS).
Zhang T; Lv H; Zhao X; Zeng N; Hui Y; Chen S; Wu N; Xu M; Wu Y; Xing A; Shi H; Zhang S; Liang X; Wang Y; Wu S; Cui L; Wang Z; Liu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111000. PubMed ID: 38580007
[TBL] [Abstract][Full Text] [Related]
18. Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study.
Ekenze O; Pinheiro A; Demissie S; Aparicio HJ; Charidimou A; Beiser AS; Satizabal CL; Kautz T; DeCarli C; Greenberg S; Seshadri S; Romero JR
J Alzheimers Dis; 2023; 95(3):1133-1145. PubMed ID: 37661877
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers and MRI visible perivascular spaces: The Framingham Heart Study.
Ekenze O; Pinheiro A; Demissie S; Charidimou A; Beiser AS; Vasan RS; Benjamin EJ; DeCarli C; Seshadri S; Romero JR
Neurobiol Aging; 2023 Jul; 127():12-22. PubMed ID: 37018882
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders.
Momota Y; Bun S; Hirano J; Kamiya K; Ueda R; Iwabuchi Y; Takahata K; Yamamoto Y; Tezuka T; Kubota M; Seki M; Shikimoto R; Mimura Y; Kishimoto T; Tabuchi H; Jinzaki M; Ito D; Mimura M
Sci Rep; 2024 Apr; 14(1):7633. PubMed ID: 38561395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
